FASLG and colorectal carcinoma: Because the elevated proportion of FasL+ DCs was not observed during our study and the concentration of soluble FasL was extremely low, we could conclude that FasL was not engaged in the cytotoxicity against FasR+ lymphocytes and CRC cancer cells under the conditions of our experiments.